MicroRNA-9 and breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MicroRNA-9 and breast cancer

Published:2020-02 Issue: Volume:122 Page:109687
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Li Xiaoman,Zeng Zhu,Wang Jiaer,Wu Yuanyuan,Chen Wenxing,Zheng Lufeng,Xi Tao,Wang Aiyun,Lu Yin

Funder

National Nature Science Foundation of China

Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference43 articles.

1. Cancer Statistics, 2017;Siegel;CA Cancer J. Clin.,2017

2. Key microRNAs in the biology of breast cancer; emerging evidence in the last decade;Khordadmehr;J. Cell. Physiol.,2019

3. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring;McGuire;Cancer Metastasis Rev.,2015

4. MicroRNAs: genomics, biogenesis, mechanism, and function;Bartel;Cell,2004

5. MicroRNA therapeutics: towards a new era for the management of cancer and other diseases;Rupaimoole;Nat. Rev. Drug Discov.,2017

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2;Stem Cell Research & Therapy;2024-05-01

2. The role of miR-222-2p in exosomes secreted by hexavalent chromium-induced premature senescent hepatocytes as a SASP component;Environmental Pollution;2024-04

3. miR-30d-5p inhibits proliferation, invasion and migration of breast cancer cells by targeting SERPINE1 and promoting fatty acid β-oxidation;Aging;2024-02-22

4. miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine;Non-Coding RNA;2024-02-21

5. RNF2 is regulated by miR17-5p, miR20a-5p and miR106b-5p in breast cancer cell lines;Human Gene;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3